Innovative drugs in lung cancer: PK and PK/PD considerations

Authors

Publication Details

Journal
SPIRE - Sciences Po Institutional REpository
Published
2025-12-04
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Innovative drugs in lung cancer: PK and PK/PD considerations

Joseph Ciccolini
SPIRE - Sciences Po Institutional REpository
Lung Cancer Treatments and Mutations
article

Innovative drugs in lung cancer: PK and PK/PD considerations

Joseph Ciccolini
article en

Abstract

No abstract available for this paper.
SPIRE - Sciences Po Institutional REpository
Openalex Percentile: Top 25%
Lung Cancer Treatments and Mutations
OpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Innovative drugs in lung cancer: PK and PK/PD considerations — Joseph Ciccolini · SPIRE - Sciences Po Institutional REpository (2025) | TGRS Research Map | TGRS